News and Trends 18 Oct 2016 This New Biotech wants to Regrow Neurons to cure Parkinson’s …for more info!. Parkinson’s affects more than 10 million people worldwide. Like other neurodegenerative diseases such as Alzheimer’s or Huntington’s, current treatments cannot stop its progression, only deal with the… October 18, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2019 Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close …2017, Eli Lilly decided to walk away from the agreement – possibly due to the Phase III failure of its Alzheimer’s drug. This has left Adocia without a partner to… September 30, 2019 - 4 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
News and Trends 2 Oct 2017 CRISPR Gets Snubbed Again by the Nobel Prize Committee …well-being. This new approach could be particularly helpful for conditions that we haven’t had much luck with so far, for example, Alzheimer’s. A disrupted circadian rhythm and sleeping pattern is… October 2, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 15 Feb 2017 French Biotech bids for Crowdfunding in Neurodegenerative Disease …company has two other early-stage candidates with indications including Alzheimer’s. Currently, approved drugs for neurodegenerative diseases can treat symptoms but not stop the progression of the disease. AlzProtect’s strategy to… February 15, 2017 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jun 2018 Cambridge Biotech Raises €32M Series A Round to Treat Chronic Inflammation …A round in 2016 to develop treatments for Alzheimer’s, Parkinson’s, heart disease and cancer. While chronic inflammation may sound like a small inconvenience, it can result in serious conditions like… June 25, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Sponsored by Collaborative Drug Discovery Inc. 25 Feb 2025 How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases …are focused less on being able to cure Alzheimer’s disease in a mouse. Our aim is more about being able to test the biological hypothesis in patients.” To this end,… February 25, 2025 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jun 2017 Videos: Who won the Refresh Early-Stage Startup Battle? The Bonsai goes to… …to test 100 patients. Second came Junction Therapeutics, which is working on a treatment for Alzheimer’s Disease that hinges on modulating the permeability of the blood-brain barrier by suppressing a… June 26, 2017 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2016 Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize …for protein quality control, scientists believe that it can be used to prevent and reverse the deposition of misfolded protein aggregates typical of neurodegenerative diseases like Parkinson’s and Alzheimer’s. Worldwide,… October 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 22 May 2023 Cancer implications as new molecule can kill ‘zombie’ cells …applied in diseases where the accumulation of senescent cells plays a role, such as Alzheimer’s disease. “Perhaps an intensive dose of the drug would clean the brain and prevent the… May 22, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2017 Cutting Through the BS in Biopharma: How To Spot Hype …amount of hype, which often leads to even greater disappointment. So what’s particularly vulnerable to the hype? Alzheimer’s disease was the first area cited as a one such field, nearly… July 5, 2017 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Dec 2017 Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017 …studies. A Turning Point in the Fight Against Alzheimer’s? What a comeback! Having been included in our list of 2016’s biggest clinical fails, TauRx Therapeutics is one 2017’s success stories…. December 18, 2017 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Apr 2023 6 biotechs that have stepped into the protein degradation space …interactions. The company acknowledges that there is a need for a novel approach to target CNS diseases such as Alzheimer’s and Parkinson’s diseases as they are caused by an accumulation… April 4, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email